5 Thoughts About the DTS 9.9 Meeting
If you want the (mostly) objective summation of what happened at the Diabetes Technology Society’s meeting on September 9th in Bethesda, MD regarding blood glucose monitoring accuracy, you can go to the Strip Safely blog post that I wrote.
If you want to read my top five completely subjective thoughts on the DTS meeting, read on…
1. I want to move to Norway.
They’ve already got the process/system in place over there that doesn’t allow inaccurate meters and strips onto the market. It’s basically what DTS has proposed to do here in the U.S. and it works brilliantly over there because the government believes in the program (called SKUP) and it’s mandatory. I don’t believe that the same thing will happen in the U.S. without it being mandated by Congress, which will take a while.
Dr. Grete Monsen of Norway gave an amazing presentation and gave a lot of advocates in the room a glimmer of hope.
(I’m kidding about moving to Norway. I love their sweaters, but I’m not big on the cold weather.)
2. They’re going to have to build a bigger boat.
Yes, a Jaws reference. Why? Because diabetes advocates have teeth.
A post-market testing program is going to need a lot of people involved and a lot of funding to go with it. The room was filled with representatives from industry, clinicians, government, and patient advocates. It wasn’t a ballroom, but there was a lot of dancing around issues that must be addressed. Most of it is regulatory and governmental and financial, but Dr. David Klonoff, the president of the Diabetes Technology Society said that they will be building a roster for a steering committee to start… and it must include patient advocates. When he first mentioned the steering committee, patient advocates were not included. Someone quickly reminded him of us and we were added during his final comments.
3. Dr. Gary Puckrein is my new hero.
Sitting at the end of the esteemed panel of clinical and patient representatives who all gave their views on the need for glucose monitoring accuracy, he waited patiently as others gave their views. I’m sure that he had his talking points and was ready to add his approval to the collective voice when Dr. Elizabeth Koller began reading her prepared statement….about how for her “patient population” (i.e. Medicare and CMS), accuracy really doesn’t matter and that the tools currently available are just fine.
(Look. I’m paraphrasing, because I began to see red and stream poured from my ears. With such dispassion, she essentially told all of us that we were wasting our time sitting here, because as long as the FDA approves a meter, it’s fair game for Medicare and they’ll choose what millions of people will use. Sort of a “nanny-nanny-boo-boo – suck it up and we don’t care because we’ll do what we want and what’s cheapest” attitude.)
Dr. Puckrein was called upon to speak and instead of launching into his prepared statement, he turned to her and (again, I’m paraphrasing) told her that what she was saying was scary and that if this is how Medicare and CMS was going to play…
“We are going to come after you like dogs.”
My hero. I want that man in our corner and thankfully, he is.
4. The FDA needs a good public relations firm.
I have to tip my hat to the FDA representatives at the meeting. They’re like Timex watches – they take a licking and keep on ticking. Diabetes advocates asked over and over about enforcement and what it would take to remove an inaccurate meter and strips from the market. They never wavered in their vagueness. We expect that. What we didn’t expect was the admission that they don’t do a very good job of explaining what they can and cannot talk about in terms of enforcement. I’d love to see a PR firm get their hands dirty and revamp the forward-facing portion of the “What we do” part of the FDA’s device division website, giving all of us a better idea of what steps they can and cannot take… so that we don’t have to repeated ask and get repeatedly shut down. It was frustrating to all of us – advocates and the FDA alike.
5. We have a long road ahead. Get your boots on.
So, you may be asking… what’s next? Didn’t you get what you wanted? Aren’t we going to get better accuracy from our strips?
Answer…. Not without enforcement and making it mandatory. And funding.
It’s one thing to have a proposal. It’s another thing to make it happen.
Funding, whether through Congress or private philanthropic organizations, has to happen. This is not a “let’s get this on Kickstarter” project… this is a Dr. Evil putting his pinky up to his mouth amount of money… And it needs to continue to be funded.
Support from the government is essential and not just the “we think this is a great idea” lip service. Once the program is up and running, the data given to them has to be acted upon, especially if it is determined that some meters and strips aren’t meeting standards (Hint: some already aren’t…). Without enforcement and “if you show us the data, we’ll act on it”, this becomes another pie in the sky project. The only benefit is for those who can afford to pick and choose their meters and supplies without suffering financial setbacks because their insurance company won’t pay for the accurate ones. That’s unacceptable.
We have a long way to go…. and we will all be right there, because we want industry and government to see the faces of those that accuracy and diabetes impacts.
Every meeting. Every discussion. Every time.
Disclosure: The Diabetes Hands Foundation compensated my travel and lodging to attend the Diabetes Technology Meeting on September 9, 2013. My thoughts and feedback are my own and are not representative of the DHF or the Diabetes Advocates program.
Just a thought — if the FDA lacks the resources or authority to pull products from the market, couldn’t they just shame them? I’m thinking of the letter grades posted by health-inspectors in the windows of restaurants in Los Angeles and New York. Most earn A’s. But a place with a C in the window, though free to operate, is sure to lose a few customers. I don’t know if lower grades get shut down automatically, but I’d suspect a proprietor with a D grade would rather shut down the restaurant and fix it up than continue to operate with that scarlet letter in front.
But would insurance and Medicare take consideration of these grades? They’d probably face a legal and PR battle if they didn’t.
At the DTS meeting last week, we heard from a representative of CMS and Medicare, who essentially said: “As long as the FDA says it’s OK to be on the market, we don’t care how accurate it is…” It was disheartening, but at the same time, bolstered the resolve that accuracy is all the more important. I love the idea of letter grades, but it is unlikely that the majority of payers would care…
Well, my thought (clearly not as researched as anything you’ve done) would embrace the periodic re-inspections that the D-community wants (just as restaurants are re-inspected periodically), but wouldn’t have to do take any court-injunctive actions as a result. Simpy publicize the results. It’s not everything, but it’s a start — a compromise. (And as we’ve seen from Accu-chek, they’re eager to promote themselves as “accurate”).
In my mind, the companies that gain approval and then relax their standards are more cause to worry than those who manufacture barely-passing strips from the start; so that’s what my mind tends to zero in on.
No, I don’t expect to see a big red D-minus stamped on a vial of cheap-import test strips, though that would be a bit funny to see.
Christel, thanks so much for attending this meeting and giving us a thorough recap. Here’s hoping we can get “meeeelions” of dollars to fund this, and that the funding keeps coming, and they don’t take it from somewhere else that it’s needed. Seriously, I could go for a few less government “security” contractors. I know that’s a lot to ask for, but when it’s the right thing, it’s the right thing.